SG Americas Securities’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
SG Americas Securities's CDNA Position: Q2 2026 in Review
SG Americas Securities reduced its CareDx (CDNA) stake by 41% in Q2 2026, selling an estimated $270K and leaving 17,561 shares worth $500K. The position accounts for ﹤0.01% of the portfolio, ranked #2324.
SG Americas Securities first reported a position in CDNA in Q1 2019 and has held it in 22 quarters since. The position peaked at $4.14M in Q1 2019. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- SG Americas Securities held 17,561 shares of CareDx worth $500K as of Q2 2026.
- SG Americas Securities sold 12,388 CareDx shares in Q2 2026, an estimated $270K.
- CareDx made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2324 holding.
- SG Americas Securities first reported a position in CareDx in Q1 2019 and has held it in 22 quarters since.
- SG Americas Securities's CareDx position peaked at $4.14M in Q1 2019.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.